Label: PNV OB DHA - vitamin c, calcium, iron, vitamin d3, vitamin e, vitamin b1, vitamin b2, vitamin b3, vitamin b6, folic acid, iodine, zinc, copper, docusate sodium, docosahexaenoic acid (dha)
- NDC Code(s): 59088-115-60
- Packager: PureTek Corporation
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
If you are a consumer or patient please visit this version.
PharmaPure Rx PNV OB + DHA is a prescription prenatal/postnatal multivitamin/mineral caplet and a softgel of an essential fatty acid. The prenatal vitamin is a light purple, capsule-shaped multivitamin/mineral caplet. The caplet is imprinted with the code "P-116" on one side and is blank on the other side. The essential fatty acid DHA softgel is clear and contains a pale yellow semi-solid mixture.
Vitamin C (Ascorbic acid) 120 mg Calcium (Calcium citrate) 125 mg Iron (Carbonyl iron, Ferrous gluconate) 27 mg Vitamin D3 (Cholecalciferol) 400 IU Vitamin E (dl-alpha tocopheryl acetate)
30 IU Vitamin B1 (Thiamine HCl) 3 mg Vitamin B2 (Riboflavin)
3.4 mg Vitamin B3 (Niacinamide)
20 mg Vitamin B6 (Pyridoxine HCl) 20 mg Folic Acid 1 mg Iodine (Potassium iodide) 150 mcg Zinc (Zinc oxide)
25 mg Copper (Cupric oxide) 2 mg Docusate Sodium
Other ingredients in DHA caplet: Croscarmellose Sodium, Crospovidone, FD and C Blue #2 Aluminum Lake, Gelatin, Hydrogenated Soybean Oil, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Polydextrose, Polyethylene Glycol, Polysorbate 80, Povidone, Red Iron Oxide, Silicon Dioxide, Starch, Stearic Acid, Sucrose, Titanium Dioxide, Triacetin.
Each PNV OB+DHA softgel contains:
250 mg Docosahexaenoic Acid (DHA)
Serving Size: 1 Softgel %Daily Value Docosahexaenoic Acid (DHA)
250 mg* *Daily Value not established.
DHA is contained in the oil derived from fish (tuna). Other ingredients in DHA softgel:Gelatin, Water, Glycerin, Polysorbate 80.
May contain Vanillin.
Also contains Eicosapentaenoic Acid (EPA) and other omega-3 fatty acids.
Cloudiness of the softgel is a characteristic of natural fish oil.
Docusate sodium is a gentle and effective stool softener that protects against the discomfort of constipation.
Contains NO artificial flavors or preservatives, yeast, wheat, gluten, nuts or milk-based by-products.
PNV OB+DHA supplies important prenatal vitamins, minerals and nutrients to supplement the nutritional needs of women, before, during and after pregnancy. Deficiencies of these nutrients are common during pregnancy and lactation and should be prescribed by a physician prior to conception.
PNV OB+DHA caplet is manufactured in a drug registered cGMP (current good manufacturing practice) facility and meets or exceeds USP standards for potency, purity and dissolution. PNV OB+DHA softgel complies with the most stringent worldwide standards for fish oil and is manufactured in a NSF-Certified cGMP Facility. Close
- INDICATIONS AND USAGE:
PNV OB+DHA is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.Close
- DOSAGE AND ADMINISTRATION:
Before, during and after pregnancy, one caplet and one softgel taken by mouth daily, or as prescribed by a physician. The caplet and softgel may be taken together or at different times of the day.Close
PNV OB+DHA is contraindicated in patients with a known hypersensitivity to any of the ingredients.Close
Accidental overdose of Iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately.
Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and reduced clotting ratio (INR). Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.Close
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
Exercise caution to ensure that the prescribed dosage of DHA doses not exceed 1 gram (1,000 mg) per day.
NOTICE: Contact with moisture can discolor or erode the caplet. Close
- ADVERSE REACTIONS:
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.Close
Caution should be exercised with patients with known allergies to fish or fish by-products.
Call your doctor for medical advice about side effects. You may report suspected side effects to the FDA at 1-800-FDA-1088.
- USE IN SPECIFIC POPULATIONS:
PNV OB+DHA is not indicated for pediatric or geriatric use.Close
- HOW SUPPLIED:
PNV OB+DHA (NDC 59088-115-60) is a 30-day regimen supplied as six child-resistant blister cards each containing 5 light purple PNV OB+DHA prenatal capsule-shaped caplets NDC:59088-116-54 imprinted "P-116" and 5 pale yellow DHA softgels NDC: 59088-117-54 each.
Store at temperature 20°-25°C (68°-77°F).[See USP Controlled Room Temperature]. Keep in a cool, dry place.
- INGREDIENTS AND APPEARANCE
PNV OB DHA
vitamin c, calcium, iron, vitamin d3, vitamin e, vitamin b1, vitamin b2, vitamin b3, vitamin b6, folic acid, iodine, zinc, copper, docusate sodium, docosahexaenoic acid (dha) kit
Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:59088-115 Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:59088-115-60 6 in 1 CARTON 1 1 in 1 BLISTER PACK Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 5 Part 2 5 Part 1 of 2 PRENATAL VITAMIN
vitamin c, calcium, iron, vitamin d3, vitamin e, vitamin b1, vitamin b2, vitamin b3, vitamin b6, folic acid, iodine, zinc, copper, docusate sodium tablet
Product Information Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ASCORBIC ACID (ASCORBIC ACID) ASCORBIC ACID 120 mg CALCIUM CITRATE (CALCIUM) CALCIUM 125 mg FERROUS GLUCONATE (IRON) IRON 0.1 mg IRON PENTACARBONYL (IRON) IRON PENTACARBONYL 26.9 mg CHOLECALCIFEROL (CHOLECALCIFEROL) CHOLECALCIFEROL 400 [iU] .ALPHA.-TOCOPHEROL ACETATE, DL- (ALPHA-TOCOPHEROL) ALPHA-TOCOPHEROL 30 [iU] THIAMINE HYDROCHLORIDE (THIAMINE) THIAMINE HYDROCHLORIDE 3 mg RIBOFLAVIN (RIBOFLAVIN) RIBOFLAVIN 3.4 mg NIACINAMIDE (NIACIN) NIACIN 20 mg PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE) PYRIDOXINE HYDROCHLORIDE 20 mg FOLIC ACID (FOLIC ACID) FOLIC ACID 1 mg POTASSIUM IODIDE (POTASSIUM CATION) POTASSIUM CATION 150 ug ZINC OXIDE (ZINC) ZINC 25 mg CUPRIC OXIDE (COPPER) CUPRIC OXIDE 2 mg DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM 50 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM CROSPOVIDONE FD&C BLUE NO. 2 GELATIN HYDROGENATED SOYBEAN OIL HYPROMELLOSE 2910 (15 MPA.S) MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE POLYDEXTROSE POLYETHYLENE GLYCOL 8000 SILICON DIOXIDE STARCH, CORN STEARIC ACID SUCROSE TITANIUM DIOXIDE TRIACETIN POLYSORBATE 80 FERRIC OXIDE RED Product Characteristics Color purple (Light purple) Score no score Shape CAPSULE (capsule-shaped caplets) Size 21mm Flavor Imprint Code P116 Contains Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 06/01/2011 Part 2 of 2 DHA
docosahexaenoic acid capsule, gelatin coated
Product Information Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DOCONEXENT (DOCONEXENT) DOCONEXENT 250 mg Inactive Ingredients Ingredient Name Strength GELATIN WATER GLYCERIN POLYSORBATE 80 Product Characteristics Color yellow (pale yellow) Score no score Shape CAPSULE (Softgel) Size 21mm Flavor Imprint Code NONE Contains Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 06/01/2011 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 06/01/2011 Labeler - PureTek Corporation (785961046) Establishment Name Address ID/FEI Business Operations PureTek Corporation 785961046 manufacture, label, pack, outsourcing human drug compounding, relabel, repack